Features
Clinical Presentation, Management, and Advances in Treatment of Sickle Cell Retinopathy
Screening and monitoring can prevent visual morbidity.
By Ishrat Ahmed, MD, PhD, Adrienne W. Scott, MD
Rho Kinase Inhibitors for Diabetic Macular Edema
A sustained-release implant has promise for both DME and Wet AMD.
By Michael A. Singer, MD, Jennifer Gallagher, MD
Plasma Kallikrein Inhibition in Diabetic Macular Edema
Targeting a novel, VEGF-independent pathway of DME could preserve and recover vision.
By Andreas Maetzel, MD, PhD, Edward P. Feener, PhD
THR-149 and THR-687 for Diabetic Macular Edema
New therapeutics target RGD integrins and the plasma kallikrein system.
By Aamir A. Aziz, BS, Majid Khan, BS, Arshad M. Khanani, MD, MA, FASRS
Bacterial Sequestration by Conjunctival Mucous
Removal prior to transconjunctival procedures may lower bacterial load.
By Steven R. Bodine, MD, Charles W. Mango, MD
The Expanding Role of Anti-VEGF in the Management of Diabetic Retinopathy
Changes could represent a paradigm shift in treatment.
By Christina Y. Weng, MD, MBA
Developments in Teleophthalmology for Diabetic Retinopathy
Diabetic eye disease is a prime target for remote diagnosis and management.
By Suzanne Michalak, MD, Majda Hadziahmetovic, MD
Intraocular Long-Term Anti-Inflammatory Treatment for Noninfectious Uveitis
Sustained-release therapy could prevent long-term, irreversible structural damage and vision loss.
By Veeral S. Sheth, MD, MBA, FACS
Web Exclusives
Independently Owned, Consolidation, and Private Equity for Retina Practices
Consider the shifting ophthalmology landscape.
By Jonathan Feistmann, MD
Departments
New Pathways for Diabetic Macular Edema Therapy
Several potential therapies are in clinical trials.
By Carl D. Regillo, MD, FACS
UPFRONT: Anti-VEGF for DR in the Real World
By Peter K. Kaiser, MD
CLINICAL TRIAL DOWNLOAD: Discussing Inflammation From Brolucizumab
A conversation on next steps and clinical implications.
By Yasha Modi, MD
NEW PRODUCT APPLICATIONS: Tracking Medication Inventory Easily and Efficiently
A range of features meet the needs of a variety of practice types.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Trial data on gene therapy, proposed Medicare cuts, FDA clearance of an AI diagnostic for DR, and more.
By Jerry Helzner, contributing editor